Related Experiment Video
Updated: Feb 14, 2026

Author Spotlight: Advancing Metabolomics Analysis of Rare Hematopoietic Stem Cells
Published on: February 23, 2024
Poorly Controlled Homocystinuria: A Rare Cause of Ischemic Priapism?
Mark Johnson1, Elaine Murphy2, Amr Raheem1
1Andrology Department, University College London Hospital, London, UK.
Insights
This study presents the first case of ischemic priapism caused by homocystinuria, a metabolic disorder. Early detection and standard treatments are effective for this rare condition.
Area of Science:
- Urology
- Metabolic Disorders
- Vascular Medicine
Background:
- Homocystinuria is a rare inherited metabolic disorder characterized by high homocysteine levels.
- Hyperhomocysteinemia significantly increases the risk of thromboembolic events, contributing to mortality and morbidity.
- Elevated homocysteine levels are linked to reduced nitric oxide (NO) production, potentially affecting vascular function.
Purpose of the Study:
- To report the first documented case of ischemic priapism secondary to poorly controlled homocystinuria.
- To explore the potential pathophysiological mechanism linking homocystinuria to priapism via nitric oxide downregulation.
- To highlight the importance of considering homocystinuria in patients presenting with priapism and discuss management strategies.
Main Methods:
- Case report of a patient with ischemic priapism.
- Review of the literature on homocystinuria, hyperhomocysteinemia, and priapism.
- Discussion of the proposed pathophysiological link involving nitric oxide synthase (NOS) and related pathways.
Main Results:
- The study details the first case of ischemic priapism attributed to poorly controlled homocystinuria.
- A potential mechanism involving decreased nitric oxide (NO) bioavailability due to hyperhomocysteinemia is proposed.
- Standard priapism treatments, including aspiration, phenylephrine injection, and shunting, were effective.
Conclusions:
- Homocystinuria should be considered in the differential diagnosis of ischemic priapism, particularly in patients with suggestive features.
- Screening for elevated plasma total homocysteine may be beneficial in selected priapism cases.
- Ischemic priapism secondary to homocystinuria appears responsive to established treatment protocols.
Abstract:
We report on the 1st case of ischemic priapism secondary to poorly controlled homocystinuria. Homocystinuria is a rare, autosomal recessive, inherited disorder of metabolism that is caused by a deficiency of cystathionine synthase, leading to marked hyperhomocysteinemia. Arterial and/or venous thromboemboli are a major cause of mortality and morbidity in patients with homocystinuria. Untreated patients have a 50% chance of having a vascular event by 30 years of age. Increased homocysteine levels have been reported to upregulate prothrombotic factors and downregulate antithrombotic factors; in particular, increased homocystinuria has been found to downregulate nitric oxide (NO). Mice that are deficient in NO synthase in the cavernosal smooth muscles have a higher incidence of priapism. Decrease in NO synthase causes downregulation of cyclic guanosine monophosphate, phosphodiesterase type 5A, and Rho A/Rho-kinase. Because persistently increased homocysteine also downregulates NO, a similar mechanism could be proposed for priapism secondary to homocystinuria. In patients presenting with priapism, specific features of homocystinuria should be sought; in selected patients, screening with plasma total homocysteine might be appropriate. Ischemic priapism secondary to homocystinuria appears to respond well to the standard treatment options of aspiration, intracavernosal injection with phenylephrine, and, if required, a shunting procedure. Johnson M, Murphy E, Raheem A, Ralph D. Poorly Controlled Homocystinuria: A Rare Cause of Ischemic Priapism? Sex Med 2018;6:171-173.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Control System Problem
When forming a closed-loop system, issues can arise if the poles cross into the unstable region, leading to potential...
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Control Systems
At the heart...
Controller Configurations
Control-system compensation involves various configurations, most commonly series or cascade compensation, in which the controller...

